Carlsmed, Inc. To Participate in the J.P. Morgan 2026 Healthcare Conference
Carlsmed (Nasdaq: CARL) announced that Mike Cordonnier, Chairman and CEO, will present at the J.P.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
Carlsmed (Nasdaq: CARL) announced that Mike Cordonnier, Chairman and CEO, will present at the J.P. Morgan 2026 Healthcare Conference on Wednesday, January 14, 2026 from 4:30–5:10 PM PT in San Francisco.
Carlsmed management also said it will host one-on-one investor meetings during the conference.
Key Figures
- Conference date
- January 14, 2026
- Presentation at J.P. Morgan 2026 Healthcare Conference
- Presentation time
- 4:30–5:10 pm PT
- Scheduled J.P. Morgan conference presentation slot
Historical Context
-
U.S. launch of aprevo cervical platform with early clinical experience data.
-
Piper Sandler healthcare conference presentation and investor meetings.
-
Q3 2025 results with 98% YoY revenue growth and raised guidance.
-
Announcement of upcoming Q3 2025 earnings release and call details.
-
Appointment of a new Chief Legal Officer to support post‑IPO growth.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
CARLSBAD, Calif., Dec. 16, 2025 (GLOBE NEWSWIRE) -- Carlsmed, Inc. (Nasdaq: CARL) (“Carlsmed” or the “Company”), today announced that Mike Cordonnier, Chairman and CEO of Carlsmed will be presenting at the J.P. Morgan 2026 Healthcare conference on Wednesday, January 14th at 4:30-5:10 pm PT in San Francisco, CA. During the conference, Carlsmed Management will be hosting 1x1 investor meetings.
About Carlsmed, Inc.
Carlsmed is a medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond.
Investor Relations
Caroline Corner, PhD
IR@Carlsmed.com
Media
LeAnn Burton
Senior Director Brand Marketing
LBurton@Carlsmed.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.